This document discusses using the CRISPR-Cas9 nickase system to contract unstable trinucleotide repeats that cause neurological diseases like Huntington's disease. It introduces trinucleotide repeat disorders and describes how the CRISPR-Cas9 system can introduce single-stranded breaks instead of double-stranded breaks to contract repeats. The document outlines experiments transfecting cells with inducible GFP genes containing variable CAG repeat lengths to determine the minimum repeat size contractible by Cas9 nickase and whether double-stranded breaks from two gRNAs improve contraction efficiency.